Results 161 to 170 of about 169,996 (318)

Recurrent Huge Aortic Aneurysm, Myocardial Infarction, and Aortic Insufficiency in a Patient With Longstanding Behcet's Disease: A Case Report of a Rare Triple Presentation

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Behçet's disease is a systemic inflammatory disorder with an incompletely understood pathophysiology. Its clinical manifestations are highly diverse, affecting multiple organs throughout the body. In some cases, Behçet's disease presents with large arterial involvement, as aneurysms, which resulted from perivascular and endovascular ...
Mohammad Ali Nazarinia, Ahmad Ali Amirghofran, Helia Bazroodi, Samaneh Hasanzadeh, Afagh Atrian, Sadra Soveid   +5 more
wiley   +1 more source

Percutaneous Coronary Intervention of an Atherosclerotic Right Coronary Artery With Anomalous Origin From the Left Sinus of Valsalva: A Case Report and Literature Review

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Anomalous origin of the right coronary artery from the left sinus of Valsalva can create technical difficulties during angiography and percutaneous coronary intervention. Awareness of this anomaly and use of a systematic, evidence‐based approach are essential to achieve procedural success safely and efficiently.
Mulualem Alemayehu Gebreselassie, Kefelegn Dejene, Gashaw Solela   +2 more
wiley   +1 more source

Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery

, 2001
Deepak L. Bhatt, Derek P. Chew, Alan T. Hirsch, Peter A. Ringleb, Werner Hacke, Eric J. Topol   +5 more
openalex   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, Volume 118, Issue 4, Page 778-789, October 2025.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

Prevention of Venous Graft Sclerosis with Clopidogrel and Aspirin Combined with a Mesh Tubing in a Dog Model of Arteriovenous Bypass Grafting

, 2001
H. R. Zurbrügg, Michele Musci, S. Sänger, Andreas Gutersohn, Christoph K. W. Mülling, Ernst Wellnhofer, T Schaffner, Roland Hetzer   +7 more
openalex   +1 more source

Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Artery Disease

New England Journal of Medicine, 2017
W. Hiatt, G. Fowkes, G. Heizer, J. Berger, I. Baumgartner, P. Held, B. Katona, K. Mahaffey, L. Norgren, Schuyler W. Jones, J. Blomster, Marcus Millegård, C. Reist, M. Patel   +13 more
semanticscholar   +1 more source

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program

Clinical Pharmacology &Therapeutics, Volume 118, Issue 4, Page 876-884, October 2025.
CYP2C19 loss‐of‐function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). The impact of genotype in patients undergoing PCI for stable ischemic heart disease (SIHD) in real‐world populations is less clear.
Catherine Chanfreau‐Coffinier, Kevin A. Friede, Mary E. Plomondon, Kyung Min Lee, Zhenyu Lu, Tia Dinatale, Scott L. DuVall, Jason L. Vassy, Stephen W. Waldo, John H. Cleator, Thomas M. Maddox, Daniel J. Rader, Themistocles L. Assimes, Scott M. Damrauer, Philip S. Tsao, Kyong‐Mi Chang, Deepak Voora, Julie A. Lynch, Jay Giri, VA Million Veteran Program, Sony Tuteja   +20 more
wiley   +1 more source

Individual variations of platelet inhibition after loading doses of clopidogrel [PDF]

, 2002
Petter Järemo, Tomas Lindahl, Sven‐Göran Fransson, Arina Rich­ter   +3 more
openalex   +1 more source

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

New England Journal of Medicine, 2013
Klopidogrel S Aspirinem, naopak nezpůsobila, vyšší výskyt, hemorhagických komplikací, než léčba, Yongjun Wang, Yilong Wang, Chunxue Wang, L. Cui, J. Zeng, S. Mekaru   +10 more
semanticscholar   +1 more source

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study

Clinical Pharmacology &Therapeutics, Volume 118, Issue 4, Page 803-812, October 2025.
The Ubiquitous Pharmacogenomics consortium (www.upgx.eu) has recently completed and published the Preemptive Pharmacogenomic Testing for Preventing Adverse Drug Reactions (PREPARE) study on the implementation of panel‐based pharmacogenetic testing. PREPARE has provided interesting lessons for the design, execution, and interpretation of future clinical
Henk‐Jan Guchelaar, Cathelijne H. van der Wouden, Lisanne E. N. Manson, Heshu Abdullah‐Koolmees, Kathrin Blagec, Tanja Blagus, Stefan Böhringer, Erika Cecchin, Ka‐Chun Cheung, Vera H. M. Deneer, Siv Jonsson, Candace Joefield‐Roka, Katja S. Just, Mats O. Karlsson, Lidija Konta, Rudolf Koopmann, Marjolein Kriek, Thorsten Lehr, Christina Mitropoulou, Victoria Rollinson, Rossana Roncato, Matthias Samwald, Elke Schaeffeler, Maria Skokou, Matthias Schwab, Daniela Steinberger, Julia C. Stingl, Roman Tremmel, Richard M. Turner, Mandy H. van Rhenen, Cristina L. Dávila‐Fajardo, Vita Dolžan, George P. Patrinos, Munir Pirmohamed, Gere Sunder‐Plassmann, Giuseppe Toffoli, Jesse J. Swen, Ubiquitous Pharmacogenomics Consortium   +37 more
wiley   +1 more source